Skip to content
SPECIFICTION
Get listed

JBI SUMARI vs RevMan

JBI SUMARI

sumari.jbi.global

RevMan

cochrane.org

Side by side

FigureJBI SUMARIRevMan
Price from$10.83/mo£6.67/mo
Free plan—Yes
Free trialYesYes
Open source——
WebYesYes
Windows—Yes
macOS—Yes
Linux—Yes
Plans published211
Spec score · Literature Review Software7.9 (#11)8.7 (#3)
Spec score · Systematic Review Software8.0 (#12)8.7 (#3)
HeadquartersNorth Adelaide, South Australia, AustraliaLondon, United Kingdom
IntegrationsThe support page describes integration with JBI evidence-based resources for methodological consistency.RevMan can import study data and references from Covidence, and RIS reference imports can use data from Crossref, PubMed, or CRS.
PurposeJBI SUMARI is a web application for conducting systematic reviews of literature, from protocol development through reporting.RevMan is Cochrane’s software for producing transparent systematic reviews, guiding authors from structured data entry and analysis through result visualization.
SupportUsers can access a SUMARI knowledge base and contact the JBI support desk; organizational subscribers are directed to their appropriate support contact.Cochrane directs users to its Support Team and provides how-to articles, screencasts and release notes.

Plans

JBI SUMARI

  • Individual subscription$130 a year
  • Organization subscriptionPriced on request

JBI SUMARI pricing →

RevMan

  • Cochrane author accessFree
  • Cochrane author accessFree
  • Practice reviewFree
  • Individual student annual subscription£80 a year
  • Student£80 a year
  • Academic£100 a year
  • Individual academic annual subscription£100 a year
  • Individual standard annual subscription£130 a year
  • Standard rate£130 a year
  • OrganizationPriced on request

RevMan pricing →

In their own words

JBI SUMARI

JBI SUMARI has no write-up on Specifiction yet; its figures are above.

Visit sumari.jbi.global

RevMan

RevMan is Cochrane’s software for building systematic reviews, from structured data entry and analysis to presenting results. It supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. Authors can edit separate parts of a review at the same time and see who else is working on it. Analysis options include pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel, and inverse-variance models. Built-in outputs include forest, SROC, and funnel plots, risk-of-bias assessments, and PRISMA flow diagrams. Authors can work from ready-made or custom templates and structured headings with Cochrane methodological guidance. RevMan imports study data and references from Covidence, and RIS reference imports can draw on Crossref, PubMed, or CRS. A free practice review is deleted after 30 days and permits one person, with no data export. Free access is also available to authors working on Cochrane Reviews. Individual annual plans are £80 a year for eligible students, £100 a year for eligible academics, and £130 a year for standard subscriptions; VAT applies in the EU and UK.

Visit cochrane.org